Petros Pharmaceuticals, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
PTPI on Nasdaq
Location
1185 Avenue Of The Americas, 3 Rd Floor, New York, NY

There are no Buy or Sell transactions made by insiders since 10/15/2024

Petros Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John D. Shulman Director, 10%+ Owner $19.6M Dec 22, 2021
Mitchell Arnold Vice Pres. of Finance & Chief Acc. Off. Feb 19, 2025
Wayne Remell Walker Director Feb 19, 2025
Fady Boctor Princ. President & Chief Comm. Officer Feb 19, 2025
Bruce Bernstein Director Feb 19, 2025
Joshua Silverman Director Feb 19, 2025
Greg Bradley Director Dec 21, 2023
Andrew Gesek President, Timm Medical May 11, 2021
Metuchen Therapeutics, LLC 10%+ Owner Mar 23, 2021

Recent Insider Transactions by Companies or Individuals for Petros Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.